The European Union’s drug regulator ruled Thursday that despite concerns over blood-clotting and suspensions by a dozen European nations, the Oxford-AstraZeneca vaccine is “safe and effective” to use. The blessing will restart Europe’s sluggish vaccine rollout, which has relied heavily on the British-Swedish product. In a press briefing Thursday afternoon, the European Medicines Agency Director Emer Cooke said that it would continue to study reports of blood-clotting and recommend warning vaccine takers of potential risks of rare clotting. Cooke said seven million people had taken the vaccine so far, and that it has been proven as a reliable tool in the battle to end the pandemic. Several European countries said they would immediately restart inoculating with AstraZeneca if the EMA gave the green light.
TOP 10 RIGHT NOW